Dalacin/Dalacin C

Dalacin/Dalacin C

clindamycin

Manufacturer:

Pfizer

Distributor:

IQVIA
Concise Prescribing Info
Contents
Clindamycin (Cap: HCl; Inj: phosphate)
Indications/Uses
Infections caused by susceptible anaerobic bacteria, strains of gm +ve aerobic bacteria (eg, Strep, Staph & Pneumococci) & Chlamydia trachomatis eg, upper & lower resp tract, skin & soft tissue, non-limb- & limb-threatening diabetic foot, bone & joint, gynecological, intra-abdominal & dental infections, septicemia & endocarditis, toxoplasmic encephalitis in combination w/ pyrimethamine & Pneumocystis jirovecii pneumonia in patients w/ AIDS, malaria including multi-resistant Plasmodium falciparum in combination w/ quinine. Prophylaxis of endocarditis in patients sensitive/allergic to penicillins; neck & head surgery infection. In combination w/ aminoglycoside (eg, gentamicin or tobramycin) in preventing peritonitis or intra-abdominal abscess after bowel perforation & bacterial contamination secondary to trauma.
Dosage/Direction for Use
β-hemolytic streptococcal infections Continue treatment for at least 10 days. Toxoplasmic encephalitis in patients w/ AIDS 600-1,200 mg IV/PO every 6 hr for 2 wk followed by 300-600 mg PO every 6 hr + pyrimethamine 25-75 mg PO daily for 8-10 wk. Give folinic acid 10-20 mg daily for higher doses of pyrimethamine. Duration of therapy: 8-10 wk. Pneumocystis carinii pneumonia in patient w/ AIDS 600-900 mg IV every 6 hr or 900 mg IV every 8 hr or 300-450 mg PO every 6 hr for 21 days + primaquine 15-30 mg PO once daily for 21 days. Severe malaria Adult 10 mg/kg quinidine gluconate IV as loading dose over 1-2 hr, then 0.02 mg/kg/min continuous infusion for at least 24 hr. Once parasite density <1% & patient can take oral medication, complete treatment w/ oral quinine + clindamycin 20 mg/kg daily divided tid for 7 days. If patient cannot take oral medication, give 10 mg/kg IV clindamycin loading dose followed by 5 mg/kg IV every 8 hr. Switch to oral clindamycin as soon as patient can take oral medication. Treatment course: 7 days. Childn Same quinidine gluconate adult dose + oral clindamycin 20 mg/kg daily divided tid for 7 days. If patient cannot take oral medication, give 10 mg/kg clindamycin loading dose IV followed by 5 mg/kg IV every 8 hr. Switch to oral clindamycin as soon as patient can take oral medication. Treatment course: 7 days. Cap Adult 600-1,800 mg daily divided in 2, 3, or 4 equal doses. Childn >1 mth who are able to swallow cap 8-25 mg/kg daily in 3 or 4 equal doses. Mild/moderate diabetic foot infections 300 mg tid-qid for 7-14 days. Chlamydia trachomatis cervicitis 450-600 mg qid for 10-14 days. Acute streptococcal tonsilitis/pharyngitis 300 mg bid for 10 days. Uncomplicated malaria/Plasmodium falciparum Quinine sulfate 650 mg (in adult) or 10 mg/kg (in childn) tid for 3-7 days + clindamycin 20 mg/kg daily divided tid for 7 days. Prophylaxis of endocarditis in patients sensitive to penicillin 600 mg (in adult) or 20 mg/kg (in childn) 1 hr before procedure. Alternatively, 600 mg IV 1 hr before procedure when parenteral administration is required. Inj Administer IM as undiluted. Administer IV as diluted then infuse over at least 10-60 min. Adult Intra-abdominal, female pelvis, other complicated & serious infections 2,400-2,700 mg IM/IV given in 2, 3, or 4 equal doses. Less complicated infections due to more susceptible microorganisms 1,200-1,800 mg IM/IV daily given in 2, 3, or 4 equal doses. Max daily dose: 4,800 mg. Childn >1 mth 20-40 mg/kg daily in 3 or 4 equal doses. Neonates (<1 mth) 15-20 mg/kg daily in 3 or 4 equal doses. Pelvic inflammatory disease 900 mg IV every 8 hr + IV antibiotic w/ appropriate gm -ve aerobic spectrum. Continue IV for at least 4 days & at least 48 hr after improvement, then continue w/ clindamycin 450-600 mg PO every 6 hr to complete 10-14 days total therapy. Prophylaxis of infection in head & neck surgery 900 mg diluted in 1,000 mL normal saline as intraoperative irrigant in contaminated head & neck surgery prior to wound closure.
Administration
May be taken with or without food: Swallow whole w/ a full glass of water to avoid oesophageal irritation.
Contraindications
Hypersensitivity to clindamycin or lincomycin.
Special Precautions
Discontinue treatment if hypersensitivity or severe skin reaction (eg, DRESS, SJS, TEN & acute generalized exanthematous pustulosis) occurs. Not to be used in treatment of meningitis. Pseudomembranous & antibiotic-associated colitis; Clostridium difficile-associated diarrhea. Perform LFTs for prolonged therapy. Monitor renal function during therapy in patients w/ pre-existing renal dysfunction or taking concomitant nephrotoxic drugs & if therapy is prolonged. Acute kidney injury & renal failure. Pregnancy & lactation. Inj: Not to be inj IV undiluted as bolus. Not to administer >1,200 mg by IV infusion in single 1-hr period. Not recommended to administer single IM doses >600 mg. Overgrowth of non-susceptible organisms, particularly yeasts. Gasping syndrome in premature & low birth wt infants due to benzyl alcohol content.
Adverse Reactions
Pseudomembranous colitis; eosinophilia; thrombophlebitis; diarrhea; maculopapular rash; abnormal LFT. TEN, SJS, DRESS.
Drug Interactions
Enhanced action of neuromuscular blocking agents. Reduced clearance w/ CYP3A4 & CYP3A5 inhibitors. Increased clearance w/ CYP3A4 & CYP3A5 inducers.
MIMS Class
Other Antibiotics
ATC Classification
J01FF01 - clindamycin ; Belongs to the class of lincosamides. Used in the systemic treatment of infections.
Cap: D; Inj: S
Presentation/Packing
Form
Dalacin cap 300 mg
Packing/Price
20's
Form
Dalacin C inj 150 mg/mL
Packing/Price
4 mL x 1's;6 mL x 1's
/thailand/image/info/dalacin c inj 150 mg-ml/150 mg-ml x 4 ml?id=d6951bad-4b7e-4711-9f1d-ad6000a204bb
/thailand/image/info/dalacin c inj 150 mg-ml/150 mg-ml x 6 ml?id=98ee32d2-dbee-4e6a-b823-ad6000a204bb
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in